UK Markets open in 2 hrs 26 mins
  • NIKKEI 225

    23,090.93
    -241.01 (-1.03%)
     
  • HANG SENG

    24,466.90
    -119.70 (-0.49%)
     
  • CRUDE OIL

    35.95
    -0.22 (-0.61%)
     
  • GOLD FUTURES

    1,871.80
    +3.80 (+0.20%)
     
  • DOW

    26,659.11
    +139.16 (+0.52%)
     
  • BTC-GBP

    10,366.40
    -63.63 (-0.61%)
     
  • CMC Crypto 200

    262.06
    +19.38 (+7.99%)
     
  • Nasdaq

    11,185.59
    +180.72 (+1.64%)
     
  • ^FTAS

    3,152.13
    -3.12 (-0.10%)
     

Worldwide Adjuvants Industry (2020 to 2025) - by Application and Geography

Research and Markets
·7-min read

Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Adjuvants Market Analysis - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

'Adjuvant' is derived from the Latin, word 'adjuvare' which translated to English means 'to help'. Adjuvants are hence designed to helping to improve poorly immunogenic vaccines. Adjuvants were originally described as substances which when used in combination with a specific antigen that produce a more robust immune response than the antigen alone, thus encompassing a wide range of materials. Vaccines efficacy has been reduced significantly due to the demand for the vaccines that are less reactive and safer for intake and at the same time also capable of inducing cell-mediated immunity hence there have been significant developments to produce such products for plants, animals as well as in human vaccines.

Adjuvants can be categorized into two broad groups; the particulate vaccine-delivery systems and the immune stimulatory adjuvants on the basis of their action mechanism which is not yet determined clearly due to complex course of action but still based on generalized results research has continued and results also achieved. .

What are Adjuvants?

Adjuvants can be defined as the substances which help to enhance the immunogenicity of an antigen for e.g. aluminum hydroxide or phosphate are used for this purpose. Many molecules including mineral compounds (e.g. Alum), water-in-oil or oil-in-water emulsions, as well as natural and synthetic toxins derived from bacteria (e.g. cholera toxin, CT and lymphotoxin, LT) have been considered for use as an adjuvant. They activate the innate immune system such that it responds more rapidly to infection and for the adaptive immune response to becomes more specific. Their working mechanisms still remain undiscovered to complete level due to the complexity of the immune response, but generalizations can be drawn in order to allow the design of more rational adjuvants aimed at particular arms of the immune system. They act on both plants as well as animals hence have wide range of applications too.

What are the major applications for Adjuvants?

Adjuvants are used as additive in all types of medicine i.e. for plants, animals and humans too. In human medicine they are added to the solution for treatment of diseases such as viral, influenza, etc. Inflammation, tissue destruction, and the potential for resulting pain and distress in the host animal arises due to immunostimulatory properties of adjuvants. Adjuvants that are used for experimental purposes are used to produce antibodies for use in other experimental or diagnostic procedures. Emulsions are the most commonly used depot agents in the experimental production of polyclonal antibodies. Emulsions may be water-in-oil emulsions, oil-in-water emulsions, or more complex types such as water-oil-water emulsions. In addition to carrying and protecting the antigen from proteolytic destruction, an adjuvant should preserve the conformational integrity of an antigen and present the antigen to the appropriate effector cells, usually professional antigen-presenting cells and macrophages. Immunomodulators and immunostimulators are used in many adjuvants to recruit, activate, and enhance differentiation of the cells of the immune system.

Market Research and Market Trends of Adjuvants Ecosystem

  • Europe and North America are the dominant markets for adjuvants because of the high prevalence of cancer in the two continents. The developed healthcare facilities, favorable reimbursements policies, and the greater means of people to spend on better quality healthcare also have contributed to adoption of adjuvants in the medicine. Knowledge of the disease and availability of various treatments is also driving the growth of the two regional markets. 90% of countries in European continent have been reported offering these cancer treatment services that include cancer surgery, subsidized chemotherapy and cancer centers or departments.

  • Agrochemicals are expected to be on high demand in future with the growing significance for technological assistance platforms such as precision farming. Global agricultural adjuvants market expansion is projected to be further pushed by the rising use of advance agrochemicals for use as herbicides, pesticides, insecticides, etc. Precision farming facilitates the use of agricultural adjuvants for suitable agrochemical application this has already resulted in tremendous benefits for farmers.

  • Vaccines are the most efficient tool for prevention of diseases that are caused by infectious pathogens. Significant progress has been made in vaccine development in the recent past, resulting in the eradication or control of several diseases. The emergence of new pathogens and the inadequate protection provided by some existing vaccines however require formulation of new vaccination strategies. Immunization approaches such as subunit vaccines and mucosal administration, essentially make the use of novel adjuvants. However, only a limited number of adjuvants are available on the market at present. There are many human vaccines which are currently in the research and development phase hence a need there is need for new solutions.

Who are the Major Players in Adjuvants market?

The players profiled in the report include BASF SE, Syngenta AG, Bayer CropScience AG, Novozymes A/S, Koppert Biological Systems B.V., Monsanto Company Inc., Marrone Bio Innovations, Inc., Biobest N.V., Certis USA LLC, Andermatt Biocontrol AG

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2019-2025.

Key Takeaways from this Report

  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.

  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

Key Topics Covered:

1. Adjuvants - Market Overview

2. Executive Summary

3. Adjuvants - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis

4. Adjuvants - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Adjuvants Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Adjuvants Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Suppliers/Distributors Analysis

6. Adjuvants Market - By Application:
6.1. Agrochemicals (Insecticides, Fungicides, Herbicides, and Fertilizers),
6.2. Surfactants,
6.3. Pharmaceuticals and
6.4. Others

7. Adjuvants Market - By Geography:
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Rest of North America
7.3. Europe
7.3.1. France
7.3.2. Germany
7.3.3. Italy
7.3.4. Spain
7.3.5. U.K
7.3.6. Rest of Europe
7.4. APAC
7.4.1. Australia
7.4.2. China
7.4.3. India
7.4.4. Japan
7.4.5. Rest of APAC
7.5. ROW
7.5.1. Middle East & Africa
7.5.2. South America

8. Market Entropy
8.1. New Product Launches
8.2. M&As, Collaborations, JVs and Partnerships

9. Company Profiles
9.1. AkzoNobel N.V.,
9.2. Croda International PLC,
9.3. Evonik Industies AG,
9.4. Huntsman Corporation,
9.5. Solvay SA,
9.6. Helena Chemical Company,
9.7. Novavax, Inc.,
9.8. Adjuvant Partners, LLC and
9.9. OZ Biosciences Inc.

10. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/mzcsnb

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900